Literature DB >> 6328526

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.

J Yates, N Warren, D Reisman, B Sugden.   

Abstract

The Epstein-Barr viral (EBV) genome of approximately equal to 170 kilobase pairs (kbp) is maintained as a plasmid in human B lymphoblasts transformed by the virus. We have identified a cis-acting element within 1.8 kbp of the viral genome that allows recombinant plasmids carrying it to be selected at high frequency and maintained as plasmids in cells latently infected by EBV. This functional element(s) requires a segment of DNA at least 800 bp and at most 1800 bp long, which contains a family of 30-bp tandem repeats at one end. Since this region confers efficient stable replication only to plasmids transfected into cells containing EBV genomes, its function probably requires trans-acting products encoded elsewhere in the viral genome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328526      PMCID: PMC345309          DOI: 10.1073/pnas.81.12.3806

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

Authors:  T Lindahl; A Adams; G Bjursell; G W Bornkamm; C Kaschka-Dierich; U Jehn
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Similarity of nucleotide sequences around the origin of DNA replication in mouse polyoma virus and simian virus 40.

Authors:  E Soeda; G Kimura; K Miura
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

4.  Electron microscopic analysis of chromosome metabolism in the Drosophila melanogaster embryo.

Authors:  S L McKnight; M Bustin; O L Miller
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1978

Review 5.  Adenovirus DNA: structure and function of a novel replicon.

Authors:  E L Winnacker
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

6.  Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments.

Authors:  J R Arrand; L Rymo; J E Walsh; E Björck; T Lindahl; B E Griffin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

7.  Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue.

Authors:  E Frost; J Williams
Journal:  Virology       Date:  1978-11       Impact factor: 3.616

8.  A specific endonuclease from Bacillus caldolyticus.

Authors:  A H Bingham; T Atkinson; D Sciaky; R J Roberts
Journal:  Nucleic Acids Res       Date:  1978-10       Impact factor: 16.971

9.  Intracellular forms of Epstein-Barr virus DNA in human tumour cells in vivo.

Authors:  C Kaschka-Dierich; A Adams; T Lindahl; G W Bornkamm; G Bjursell; G Klein; B C Giovanella; S Singh
Journal:  Nature       Date:  1976-03-25       Impact factor: 49.962

10.  Replication of ribosomal DNA in Xenopus laevis.

Authors:  I Bozzoni; C T Baldari; F Amaldi; M Buongiorno-Nardelli
Journal:  Eur J Biochem       Date:  1981-09-01
View more
  308 in total

1.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.

Authors:  M A Lee; M E Diamond; J L Yates
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  The linking regions of EBNA1 are essential for its support of replication and transcription.

Authors:  D Mackey; B Sugden
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression.

Authors:  S Fujiwara; Y Nitadori; H Nakamura; T Nagaishi; Y Ono
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 5.  Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  G Niedobitek
Journal:  Mol Pathol       Date:  2000-10

Review 6.  Evolutionary aspects of oncogenic herpesviruses.

Authors:  J Nicholas
Journal:  Mol Pathol       Date:  2000-10

7.  Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression.

Authors:  X Wang; W Zeng; M Murakawa; M W Freeman; B Seed
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.

Authors:  M A Cotter; E S Robertson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis.

Authors:  R S Maser; O K Mirzoeva; J Wells; H Olivares; B R Williams; R A Zinkel; P J Farnham; J H Petrini
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

10.  The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.

Authors:  E R Leight; B Sugden; E R Light
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.